Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Acorda_Therapeutics
|
| gptkbp:focus |
neurological diseases
|
| gptkbp:founded |
gptkb:2011
|
| gptkbp:founder |
Robin Elliott
|
| gptkbp:headquarters |
gptkb:Boston,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Civitas Therapeutics
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:key_people |
gptkb:David_A._Kessler
gptkb:David_A._S._Kessler gptkb:Robert_A._Mc_Carthy gptkb:Michael_A._Mc_Carthy Robin Elliott |
| gptkbp:products |
CVT-301
|
| gptkbp:type |
private company
|
| gptkbp:website |
www.civitastx.com
|
| gptkbp:bfsParent |
gptkb:Teleflex
gptkb:Acorda_Therapeutics |
| gptkbp:bfsLayer |
5
|